352 related articles for article (PubMed ID: 19279103)
1. Nonreplicating vaccinia virus vectors expressing the H5 influenza virus hemagglutinin produced in modified Vero cells induce robust protection.
Mayrhofer J; Coulibaly S; Hessel A; Holzer GW; Schwendinger M; Brühl P; Gerencer M; Crowe BA; Shuo S; Hong W; Tan YJ; Dietrich B; Sabarth N; Savidis-Dacho H; Kistner O; Barrett PN; Falkner FG
J Virol; 2009 May; 83(10):5192-203. PubMed ID: 19279103
[TBL] [Abstract][Full Text] [Related]
2. Broad protection against avian influenza virus by using a modified vaccinia Ankara virus expressing a mosaic hemagglutinin gene.
Kamlangdee A; Kingstad-Bakke B; Anderson TK; Goldberg TL; Osorio JE
J Virol; 2014 Nov; 88(22):13300-9. PubMed ID: 25210173
[TBL] [Abstract][Full Text] [Related]
3. Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques.
Florek KR; Weinfurter JT; Jegaskanda S; Brewoo JN; Powell TD; Young GR; Das SC; Hatta M; Broman KW; Hungnes O; Dudman SG; Kawaoka Y; Kent SJ; Stinchcomb DT; Osorio JE; Friedrich TC
J Virol; 2014 Nov; 88(22):13418-28. PubMed ID: 25210172
[TBL] [Abstract][Full Text] [Related]
4. Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.
Kamlangdee A; Kingstad-Bakke B; Osorio JE
J Virol; 2016 Aug; 90(15):6771-6783. PubMed ID: 27194759
[TBL] [Abstract][Full Text] [Related]
5. Recombinant parainfluenza virus 5 vaccine encoding the influenza virus hemagglutinin protects against H5N1 highly pathogenic avian influenza virus infection following intranasal or intramuscular vaccination of BALB/c mice.
Mooney AJ; Li Z; Gabbard JD; He B; Tompkins SM
J Virol; 2013 Jan; 87(1):363-71. PubMed ID: 23077318
[TBL] [Abstract][Full Text] [Related]
6. Cross-protective efficacy of bivalent recombinant baculoviral vaccine against heterologous influenza H5N1 challenge.
Prabakaran M; Kolpe AB; He F; Kwang J
Vaccine; 2013 Feb; 31(10):1385-92. PubMed ID: 23328313
[TBL] [Abstract][Full Text] [Related]
7. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
[TBL] [Abstract][Full Text] [Related]
8. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of parainfluenza virus 5 mutants expressing hemagglutinin from H5N1 influenza A virus in mice.
Li Z; Gabbard JD; Mooney A; Chen Z; Tompkins SM; He B
J Virol; 2013 Sep; 87(17):9604-9. PubMed ID: 23804633
[TBL] [Abstract][Full Text] [Related]
10. Site-Specific Glycan-Masking/Unmasking Hemagglutinin Antigen Design to Elicit Broadly Neutralizing and Stem-Binding Antibodies Against Highly Pathogenic Avian Influenza H5N1 Virus Infections.
Chen TH; Yang YL; Jan JT; Chen CC; Wu SC
Front Immunol; 2021; 12():692700. PubMed ID: 34335603
[TBL] [Abstract][Full Text] [Related]
11. Progress toward a universal H5N1 vaccine: a recombinant modified vaccinia virus Ankara-expressing trivalent hemagglutinin vaccine.
Prabakaran M; Leyrer S; He F; Auer S; Kumar SR; Kindsmueller K; Mytle N; Schneider J; Lockhart S; Kwang J
PLoS One; 2014; 9(9):e107316. PubMed ID: 25229722
[TBL] [Abstract][Full Text] [Related]
12. Vectors based on modified vaccinia Ankara expressing influenza H5N1 hemagglutinin induce substantial cross-clade protective immunity.
Hessel A; Schwendinger M; Holzer GW; Orlinger KK; Coulibaly S; Savidis-Dacho H; Zips ML; Crowe BA; Kreil TR; Ehrlich HJ; Barrett PN; Falkner FG
PLoS One; 2011 Jan; 6(1):e16247. PubMed ID: 21283631
[TBL] [Abstract][Full Text] [Related]
13. Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice.
Brewoo JN; Powell TD; Jones JC; Gundlach NA; Young GR; Chu H; Das SC; Partidos CD; Stinchcomb DT; Osorio JE
Vaccine; 2013 Apr; 31(14):1848-55. PubMed ID: 23376279
[TBL] [Abstract][Full Text] [Related]
14. A replicating modified vaccinia tiantan strain expressing an avian-derived influenza H5N1 hemagglutinin induce broadly neutralizing antibodies and cross-clade protective immunity in mice.
Xiao H; Liu L; Zhu Q; Tan Z; Yu W; Tang X; Zhan D; Du Y; Wang H; Liu D; Li Z; Yuen KY; Ho DD; Gao GF; Chen Z
PLoS One; 2013; 8(12):e83274. PubMed ID: 24358269
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a New Viral Vaccine Vector in Mice and Rhesus Macaques: J Paramyxovirus Expressing Hemagglutinin of Influenza A Virus H5N1.
Abraham M; Beavis AC; Xiao P; Villinger FJ; Li Z; Jones CA; Tompkins SM; He B
J Virol; 2021 Oct; 95(22):e0132121. PubMed ID: 34469242
[TBL] [Abstract][Full Text] [Related]
16. A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
Tian X; Landreth S; Lu Y; Pandey K; Zhou Y
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177192
[TBL] [Abstract][Full Text] [Related]
17. Potent adjuvant effects of novel NKT stimulatory glycolipids on hemagglutinin based DNA vaccine for H5N1 influenza virus.
Hung JT; Tsai YC; Lin WD; Jan JT; Lin KH; Huang JR; Cheng JY; Chen MW; Wong CH; Yu AL
Antiviral Res; 2014 Jul; 107():110-8. PubMed ID: 24786174
[TBL] [Abstract][Full Text] [Related]
18. Protective immunity elicited by a pseudotyped baculovirus-mediated bivalent H5N1 influenza vaccine.
Wu Q; Xiao S; Fan H; Li Y; Xu J; Li Z; Lu W; Su X; Zou W; Jin M; Chen H; Fang L
Antiviral Res; 2011 Dec; 92(3):493-6. PubMed ID: 22020305
[TBL] [Abstract][Full Text] [Related]
19. Chimpanzee adenovirus vector-based avian influenza vaccine completely protects mice against lethal challenge of H5N1.
Cheng T; Wang X; Song Y; Tang X; Zhang C; Zhang H; Jin X; Zhou D
Vaccine; 2016 Sep; 34(41):4875-4883. PubMed ID: 27576071
[TBL] [Abstract][Full Text] [Related]
20. A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations.
Hessel A; Schwendinger M; Fritz D; Coulibaly S; Holzer GW; Sabarth N; Kistner O; Wodal W; Kerschbaum A; Savidis-Dacho H; Crowe BA; Kreil TR; Barrett PN; Falkner FG
PLoS One; 2010 Aug; 5(8):e12217. PubMed ID: 20808939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
